Results for tag: "Alvocidib"

Alvocidib is an oncology drug used to treat certain types of cancer, such as chronic myelogenous leukemia (CML). It is a type of chemotherapy drug that works by inhibiting the activity of an enzyme called tyrosine kinase, which is involved in the growth and spread of cancer cells. Alvocidib is typically used in combination with other drugs, such as imatinib, to treat CML. It is also used to treat other types of cancer, such as acute myeloid leukemia (AML) and non-Hodgkin's lymphoma (NHL). Alvocidib is available in both oral and intravenous forms. It is typically prescribed by oncologists and other healthcare professionals. The drug is approved by the US Food and Drug Administration (FDA) for the treatment of CML and NHL. Some companies in the Alvocidib market include Novartis, Pfizer, and Merck. Show Less Read more